Business
Currency:EUR
2024/Q2
Stock NameRevenueRatio
Biopharmaceutical and Diagnostic Solutions223.03M85.92%
Engineering79.56M30.65%
Adjustments, eliminations and unallocated items-43.02M-16.57%
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
EMEA634.05M58.42%
North America317.54M29.26%
APAC102.9M9.48%
South America30.87M2.84%